Related Experiment Video
Updated: May 6, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Genome-wide response to antihypertensive medication using home blood pressure measurements: a pilot study nested
Kei Kamide1, Kei Asayama, Tomohiro Katsuya
1Department of Geriatric Medicine & Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan and Department of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan and Research Institute, National Cerebro & Cardiovascular Research Center, Osaka, Japan and Studies Coordinating Centre, Research Unit Hypertension & Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Insights
This study identified genetic markers associated with responses to calcium channel blockers and angiotensin II receptor blockers in hypertension patients. These findings may advance personalized hypertension treatment strategies.
Area of Science:
- Pharmacogenomics
- Cardiovascular Medicine
- Genetics
Background:
- Essential hypertension is a common cardiovascular condition.
- Treatment decisions for hypertension often involve calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACEI), or angiotensin II receptor blockers (ARB).
- Individual responses to antihypertensive medications can vary significantly.
Purpose of the Study:
- To investigate the genetic basis of blood pressure response to first-line antihypertensive treatments.
- To identify single nucleotide polymorphisms (SNPs) associated with differential drug responses in hypertension.
- To explore the potential for personalized medicine in hypertension management.
Main Methods:
- A genomic study (HOMED-BP trial) involving 265 patients with mild-to-moderate essential hypertension.
- Randomized allocation to first-line treatment with CCB, ACEI, or ARB.
- High-fidelity phenotyping using 5-day home blood pressure measurements before and after treatment.
- Genotyping using 500K DNA microarray chips and statistical analysis of blood pressure response as a quantitative trait.
- Replication of significant findings using the multicenter GEANE study.
Main Results:
- Single nucleotide polymorphisms (SNPs) in PICALM, TANC2, NUMA1, and APCDD1 were associated with CCB response.
- SNPs in ABCC9 and YIPF1 were associated with ARB response, with findings replicated in an independent study.
- No specific SNPs were reported as associated with ACEI response in the abstract.
Conclusions:
- The study highlights specific genetic variations influencing patient response to CCBs and ARBs.
- The use of high-fidelity phenotyping through home blood pressure monitoring is a valuable approach.
- This research represents a step towards personalized treatment strategies for hypertension.
Background:
Patients with mild-to-moderate essential hypertension in the HOMED-BP trial were randomly allocated to first-line treatment with a calcium channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB).
Methods:
We recruited 265 (93 for CCB, 71 for ACEI and 101 for ARB) patients who completed the genomic study. Home blood pressure was measured for 5 days off-treatment before randomization and for 5 days after 2-4 weeks of randomized drug treatment. Genotyping was performed by 500K DNA microarray chips. The blood pressure responses to the three drugs were analyzed separately as a quantitative trait. For replication of SNPs with p < 10(-4), we used the multicenter GEANE study, in which patients were randomized to valsartan or amlodipine.
Results:
SNPs in PICALM, TANC2, NUMA1 and APCDD1 were found to be associated with CCB responses and those in ABCC9 and YIPF1 were found to be associated with ARB response with replication.
Conclusion:
Our approach, the first based on high-fidelity phenotyping by home blood pressure measurement, might be a step in moving towards the personalized treatment of hypertension.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Blood Pressure
Measurement of Blood Pressure

